dasatinib ratiopharm 80 mg tabletti, kalvopäällysteinen
teva b.v. - dasatinibi monohydricum - tabletti, kalvopäällysteinen - 80 mg - dasatinibi
dasatinib ratiopharm 100 mg tabletti, kalvopäällysteinen
teva b.v. - dasatinibi monohydricum - tabletti, kalvopäällysteinen - 100 mg - dasatinibi
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
natriumklorid b. braun 9 mg/ml infuusioneste, liuos
b. braun melsungen ag - sodium chloride - infuusioneste, liuos - 9 mg/ml - elektrolyytit
feiba 25 u/ml infuusiokuiva-aine ja liuotin, liuosta varten
baxalta innovations gmbh - tekijä viii: n estäjä ohittaen toimintaa - infuusiokuiva-aine ja liuotin, liuosta varten - 25 u/ml - hyytymistekijä viii:n vasta-aineen ohittava aine
feiba 50 u/ml infuusiokuiva-aine ja liuotin, liuosta varten
baxalta innovations gmbh - tekijä viii: n estäjä ohittaen toimintaa - infuusiokuiva-aine ja liuotin, liuosta varten - 50 u/ml - hyytymistekijä viii:n vasta-aineen ohittava aine
banjo forte
adama - dimetomorf 200 g/l + fluazinam 200 g/l - kasvitautien torjunta
cloud
adama - kvinmerakki / kvinmerak 125 g/l + metatsaklori / metazaklor 375 g/l - rikkakasvien torjunta